Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders

Abstract

Summary Background The association of fructose and lactose intolerance and malabsorption with the symptoms of different functional gastrointestinal disorders ( FGID ) remains unclear. Aim To investigate the prevalence of fructose and lactose intolerance (symptom induction) and malabsorption and their association with clinical gastrointestinal ( GI ) as well as non‐ GI symptoms in FGID and the outcome of dietary intervention. Methods Fructose and lactose intolerance (defined by positive symptom index) and malabsorption (defined by increased hydrogen/methane) were determined in 1372 FGID patients in a single centre using breath testing. Results were correlated with clinical symptoms in different FGID Rome III subgroups. The effectiveness of a targeted saccharide‐reduced diet was assessed after 6–8 weeks. Results Intolerance prevalence across all FGID s was 60% to fructose, 51% to lactose and 33% to both. Malabsorption occurred in 45%, 32% and 16% respectively. There were no differences in intolerance or malabsorption prevalence between FGID subgroups. FGID symptoms correlated with symptoms evoked during testing ( r = 0.35–0.61. P < 0.0001), but not with malabsorption. Non‐ GI symptoms occurred more commonly in patients with intolerances. Methane breath levels were not associated with constipation using several cut‐off thresholds. Adequate symptom relief was achieved in >80% of intolerant patients, irrespective of malabsorption. Conclusions Fructose and lactose intolerances are common in FGID and associated with increased non‐ GI symptoms, but not with specific FGID subtypes. Symptoms experienced during breath testing, but not malabsorption, correlate with FGID symptoms. Effective symptom relief with dietary adaptation is not associated with malabsorption. Mechanisms relating to the generation of GI and non‐ GI symptoms due to lactose and fructose in FGID need to be explored further.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 53

1. 1.

   Eswaran S, Tack J, Chey W. Food: the forgotten factor in the Irritable Bowel Syndrome. Gastroenterol Clin North Am. 2011;40:141-62.

   Not in our library10.1016/j.gtc.2010.12.012

2. 2.

   Morcos A, Dinan T, Quigley AM. Irritable Bowel Syndrome: role of food in pathogenesis and management. J Dig Dis. 2009;10:237-46.

   Not in our library10.1111/j.1751-2980.2009.00392.x

3. 3.

   Gibson P. Food intolerance in functional bowel disorders. J Gastroenterol Hepatol. 2011;26(Suppl. 3):128-31.

   Not in our library10.1111/j.1440-1746.2011.06650.x

4. 4.

   Wang J, Simpson HA. Food allergy. J Clin Invest. 2011;121:827-35.

   Not in our library10.1172/jci45434

5. 5.

   Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with Irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol. 2008;6:765-71.

   Not in our library10.1016/j.cgh.2008.02.058

6. 6.

   Choi YK, Kraft N, Zimmerman B, Jackson M, Rao SS. Fructose intolerance in IBS and utility of fructose-restricted diet. J Clin Gastroenterol. 2008;42:233-8.

   Not in our library10.1097/mcg.0b013e31802cbc2f

7. 7.

   Kyaw MH, Mayberry JF. Fructose malabsorption: true condition or a variance from normality. J Clin Gastroenterol. 2011;45:16-21.

   Not in our library10.1097/mcg.0b013e3181eed6bf

8. 8.

   Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466-79.

   Not in our library10.1053/j.gastro.2005.11.059

9. 9.

   Rome III Disorders and Criteria.

   Not in our library

10. 10.

    Gasbarrini A, Corazzo GR, Gasbarrini G, et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: a Rome Consensus Conference. Aliment Pharmacol Ther. 2009;29(Suppl.1):1-49.

    Not in our library10.1111/j.1365-2036.2009.03951.x

11. 11.

    Braden B. Methods and functions: breath tests. Best Pract Res Clin Gastroenterol. 2009;23:337-52.

    Not in our library10.1016/j.bpg.2009.02.014

12. 12.

    Rao SSC, Attaluri A, Anderson L, Stumbo P. The ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol. 2007;5:959-63.

    Not in our library10.1016/j.cgh.2007.04.008

13. 13.

    Law D, Conklin J, Pimentel M. Lactose intolerance and the role of the lactose breath test. Am J Gastroenterol. 2010;105:1726-8.

    Not in our library10.1038/ajg.2010.146

14. 14.

    Gibson PR, Newnham E, Barrett JS, Shepherd SJ, Muir JG. Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther. 2007;25:349-63.

    Not in our library10.1111/j.1365-2036.2006.03186.x

15. 15.

    Matthews SB, Waud JP, Roberts AG, Campbell AK. Systemic lactose intolerance: a new perspective on an old Problem. Postgrad Med J. 2005;81:167-73.

    Not in our library10.1136/pgmj.2004.025551

16. 16.

    Campbell AK, Waud JP, Matthews SB. The molecular basis of lactose intolerance. Sci Prog. 2009;92:241-87.

    Not in our library10.3184/003685009x12547510332240

17. 17.

    Eadala P, Matthews SB, Waud JP, Green JT, Campbell AK. Association of lactose sensitivity with inflammatory bowel disease–demonstrated by analysis of genetic polymorphism, breath gases and symptoms. Aliment Pharmacol Ther. 2011;34:735-46.

    Not in our library10.1111/j.1365-2036.2011.04799.x

18. 18.

    Kunkel D, Basseri RJ, Makhani MD, Chong K, Chang C, Pimentel M. Methane on breath testing is associated with constipation: a systematic review and meta-analysis. Dig Dis Sci. 2011;56:1612-8.

    Not in our library10.1007/s10620-011-1590-5

19. 19.

    Bijkerk CJ, de Wit NJ, Muris JWM, Jones RH, Knottnerus JA, Hoes AW. Outcome measures in Irritable Bowel Syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol. 2003;98:122-7.

    Not in our library10.1111/j.1572-0241.2003.07158.x

20. 20.

    Spiller R, Garsed K. Infection, inflammation, and the Irritable bowel syndrome. Dig Liver Dis. 2009;41:844-9.

    Not in our library10.1016/j.dld.2009.07.007

21. 21.

    Spiller R, Lam C. The shifting interface between IBS and IBD. Curr Opin Pharmacol. 2011;11:586-92.

    Not in our library10.1016/j.coph.2011.09.009

22. 22.

    Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163-73.

    Not in our library10.1038/nrgastro.2010.4

23. 23.

    Kennedy PJ, Clarke G, Quigley EM, Groeger JA, Dinan TG, Cryan JF. Gut memories: towards a cognitive neurobiology of Irritable bowel syndrome. Neurosci Biobehav Rev. 2012;36:310-40.

    Not in our library10.1016/j.neubiorev.2011.07.001

24. 24.

    He T, Venema K, Priebe MG, Welling GW, Brummer RJ, Vonk RJ. The role of colonic metabolism in lactose intolerance. Eur J Clin Invest. 2008;38:541-7.

    Not in our library10.1111/j.1365-2362.2008.01966.x

25. 25.

    Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology. 2004;127:1239-55.

    Not in our library10.1053/j.gastro.2004.05.030

26. 26.

    Feinle-Bisset C, Horowitz M. Dietary factors in functional dyspepsia. Neurogastroenterol Motil. 2006;18:608-18.

    Not in our library10.1111/j.1365-2982.2006.00790.x

27. 27.

    Wilder-Smith CH, Robert-Yap J. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with Irritable bowel syndrome. World J Gastroenterol. 2007;13:3699-704.

    Not in our library10.3748/wjg.v13.i27.3699

28. 28.

    Bouin M, Lupien F, Riberdy M, Boivin M, Plourde V, Poitras P. Intolerance to visceral distension in functional dyspepsia or Irritable bowel syndrome: an organ specific defect or a pan intestinal dysregulation? Neurogastroenterol Motil. 2004;16:311-4.

    Not in our library10.1111/j.1365-2982.2004.00511.x

29. 29.

    Li X, Cao Y, Wong RK, Ho KY, Wilder-Smith CH. Visceral and somatic sensory function in functional dyspepsia. Neurogastroenterol Motil. 2013;25:246-53.

    Not in our library10.1111/nmo.12044

30. 30.

    Di Defano M, Miceli E, Missanelli A, Mazzocchi S, Tana P, Corazza GR. Role of colonic fermentation in the perception of colonic distension in Irritable bowel syndrome and functional bloating. Clin Gastroenterol Hepatol. 2006;4:1242-7.

    Not in our library10.1016/j.cgh.2006.07.004

31. 31.

    MacFarlane S, MacFarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc. 2003;62:67-72.

    Not in our library10.1079/pns2002207

32. 32.

    Rumessen JJ, Gudmand-Høyer E. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut. 1986;27:1161-8.

    Not in our library10.1136/gut.27.10.1161

33. 33.

    Zhao J, Fox M, Cong Y, et al. Lactose intolerance in patients with chronic functional diarrhoea: the role of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2010;31:892-900.

    Not in our library10.1111/j.1365-2036.2010.04252.x

34. 34.

    Beyerlein L, Pohl D, Delco F, Stutz B, Fried M, Tutuian R. Correlation between symptoms developed after the oral ingestion of 50 g lactose and results of hydrogen breath testing for lactose intolerance. Aliment Pharmacol Ther. 2008;27:659-65.

    Not in our library10.1111/j.1365-2036.2008.03623.x

35. 35.

    Bate JP, Irving PM, Barrett JS, Gibson PR. Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol. 2010;22:318-26.

    Not in our library10.1097/meg.0b013e32832b20e8

36. 36.

    Lied GA, Lillestol K, Lind R, et al. Perceived food hypersensitivity: a review of 10 years of interdisciplinary research at a reference center. Scand J Gastroenterol. 2011;46:1169-78.

    Not in our library10.3109/00365521.2011.591428

37. 37.

    Valeur J, Morken MH, Norin E, Midtvedt T, Berstad A. Carbohydrate intolerance in patients with self-reported food hypersensitivity: comparison of lactulose and glucose. Scand J Gastroenterol. 2009;44:1416-23.

    Not in our library10.3109/00365520903348684

38. 38.

    Chassard C, Dapoigny M, Scott KP, et al. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther. 2012;35:828-38.

    Not in our library10.1111/j.1365-2036.2012.05007.x

39. 39.

    Di Camillo M, Marinaro V, Argnani F, Foglietta T, Vernia P. Hydrogen breath test for diagnosis of lactose malabsorption: the importance of timing and the number of breath samples. Can J Gastroenterol. 2006;20:265-8.

    Not in our library10.1155/2006/715459

40. 40.

    Shepherd S, Gibson P. Fructose malabsorption and symptoms of Irritable Bowel Syndrome: guidelines for effective dietary management. J Am Diet Assoc. 2006;106:1631-9.

    Not in our library10.1016/j.jada.2006.07.010

41. 41.

    Fernández-Bañares F, Rosinach M, Esteve M, Forné M, Espinós JC, Maria Viver J. Sugar malabsorption in functional abdominal bloating: a pilot study on the long-term effect of dietary treatment. Clin Nutr. 2006;25:824-31.

    Not in our library10.1016/j.clnu.2005.11.010

42. 42.

    Staudacher HM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with Irritable bowel syndrome. J Hum Nutr Diet. 2011;24:487-95.

    Not in our library10.1111/j.1365-277x.2011.01162.x

43. 43.

    Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. Comorbidity in Irritable bowel syndrome. Am J Gastroenterol. 2007;102:2767-76.

    Not in our library10.1111/j.1572-0241.2007.01540.x

44. 44.

    Berstad A, Undseth R, Lind R, Valeur J. Functional bowel symptoms, fibromyalgia and fatigue: a food-induced triad? Scand J Gastroenterol. 2012;47:914-9.

    Not in our library10.3109/00365521.2012.690045

45. 45.

    Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in Irritable bowel syndrome. J Gastroenterol Hepatol. 2010;25:1366-73.

    Not in our library10.1111/j.1440-1746.2010.06370.x

46. 46.

    Campbell AK, Matthews SB, Vassel N, et al. Bacterial metabolic ‘toxins’: a new mechanism for lactose and food intolerance, and Irritable bowel syndrome. Toxicology. 2010;278:268-76.

    Not in our library10.1016/j.tox.2010.09.001

47. 47.

    Ledochowski M, Widner B, Murr C, Sperner-Unterweger B, Fuchs D. Fructose malabsorption is associated with decreased plasma tryptophan. Scand J Gastroenterol. 2001;36:367-71.

    Not in our library10.1080/003655201300051135

48. 48.

    Ledochowski M, Widner B, Murr C, Fuchs D. Decreased serum zinc in fructose malabsorbers. Clin Chem. 2001;47:745-7.

    Not in our library

49. 49.

    Ledochowski M, Widner B, Sperner-Unterweger B, Propst T, Vogel W, Fuchs D. Carbohydrate malabsorption syndromes and early signs of mental depression in females. Dig Dis Sci. 2000;45:1255-9.

    Not in our library10.1023/a:1005527230346

50. 50.

    Monnier VM. Bacterial enzymes that can deglycate glucose- and fructose-modified lysine. Biochem J. 2005;392:1-3.

    Not in our library10.1042/bj20051625

51. 51.

    Mortensen PB, Holtug K, Rasmussen HS. Short-chain fatty acid production from mono- and disaccharides in a fecal incubation system: implications for colonic fermentation of dietary fiber in humans. J Nutr. 1988;118:321-5.

    Not in our library10.1093/jn/118.3.321

52. 52.

    Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal disorders: the FODMAP approach. J Gastroenterol Hepatol. 2010;25:252-8.

    Not in our library10.1111/j.1440-1746.2009.06149.x

53. 53.

    Gibson PR, Barrett JS. The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders. Nutrition. 2010;26:1038-43.

    Not in our library10.1016/j.nut.2010.01.005

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.